<unk>  (trade name Nailin) is a triazole antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole. The Drugs for Neglected Diseases Initiative and the Japanese pharmaceutical company Eisai are studying<unk>  as a potential treatment for eumycetoma.
Fosravuconazole
Fluconazole
Itraconazole
Miconazole
Posaconazole
Levoketoconazole
Efinaconazole
Nystatin